| Literature DB >> 24856259 |
James K Kirklin1, David C Naftel2, Francis D Pagani3, Robert L Kormos4, Lynne W Stevenson5, Elizabeth D Blume6, Marissa A Miller7, J T Baldwin7, J Timothy Baldwin7, James B Young8.
Abstract
The sixth annual report of the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) summarizes the first 8 years of patient enrollment. The analysis is based on data from >10,000 patients and updates demographics, survival, adverse events and risk factors. Among patients with continuous-flow pumps, actuarial survival continues to be 80% at 1 year and 70% at 2 years. The report features a comparison of two eras of continuous-flow durable devices in the USA in terms of device strategy, patient profiles, adverse event burden, survival and quality of life.Entities:
Keywords: INTERMACS; advanced heart failure; destination therapy; mechanical support; ventricular assist device
Mesh：
Year: 2014 PMID： 24856259 DOI： 10.1016/j.healun.2014.04.010
Source DB: PubMed Journal: J Heart Lung Transplant ISSN： 1053-2498 Impact factor: 10.247